{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T20:54:24Z","timestamp":1780520064005,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100021729","name":"Cape Coral Community Foundation","doi-asserted-by":"publisher","award":["CCCF-QF-2022B76\\u201311"],"award-info":[{"award-number":["CCCF-QF-2022B76\\u201311"]}],"id":[{"id":"10.13039\/100021729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LTGC24B050006"],"award-info":[{"award-number":["LTGC24B050006"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LTGC23H200001"],"award-info":[{"award-number":["LTGC23H200001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015406","name":"Tianjin Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["21ZXJBSY00050"],"award-info":[{"award-number":["21ZXJBSY00050"]}],"id":[{"id":"10.13039\/501100015406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270565"],"award-info":[{"award-number":["82270565"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jpba.2025.117182","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:38:52Z","timestamp":1760027932000},"page":"117182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Quantification of active and total adalimumab using affinity purification coupled with tryptic digestion-based liquid chromatography-tandem mass spectrometry analysis"],"prefix":"10.1016","volume":"268","author":[{"given":"Xiaoran","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7008-9816","authenticated-orcid":false,"given":"Yifei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengxuan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0752-0922","authenticated-orcid":false,"given":"Junming","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyue","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaocang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengjie","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2025.117182_bib1","doi-asserted-by":"crossref","first-page":"G161","DOI":"10.1152\/ajpgi.00142.2014","article-title":"Redeeming an old foe: protective as well as pathophysiological roles for tumor necrosis factor in inflammatory bowel disease","volume":"308","author":"Dub\u00e9","year":"2015","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jpba.2025.117182_bib2","doi-asserted-by":"crossref","first-page":"10273","DOI":"10.3390\/ijms221910273","article-title":"Tumor necrosis factor's pathway in crohn's disease: potential for intervention","volume":"22","author":"Pagnini","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.jpba.2025.117182_bib3","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/ecco-jcc\/jjw053","article-title":"Mechanism of action of Anti-TNF therapy in inflammatory bowel disease","volume":"10","author":"Levin","year":"2016","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.jpba.2025.117182_bib4","first-page":"Cd012877","article-title":"Adalimumab for maintenance of remission in crohn's disease","volume":"5","author":"Townsend","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jpba.2025.117182_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12014-024-09464-x","article-title":"Highly sensitive therapeutic drug monitoring of infliximab in serum by targeted mass spectrometry in comparison to ELISA data","volume":"21","author":"Hentschel","year":"2024","journal-title":"Clin. Proteom."},{"key":"10.1016\/j.jpba.2025.117182_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115543","article-title":"Multi-attribute method (MAM) to assess analytical comparability of adalimumab biosimilars","volume":"234","author":"Mill\u00e1n-Mart\u00edn","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117182_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/17460441.2021.1846516","article-title":"Preclinical discovery and development of adalimumab for the treatment of rheumatoid arthritis","volume":"16","author":"Pelechas","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.jpba.2025.117182_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40259-023-00641-2","article-title":"Reducing immunogenicity by design: approaches to minimize immunogenicity of monoclonal antibodies","volume":"38","author":"Harris","year":"2024","journal-title":"BioDrugs"},{"key":"10.1016\/j.jpba.2025.117182_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40259-020-00458-3","article-title":"Systematic review and principal components analysis of the immunogenicity of adalimumab","volume":"35","author":"Borrega","year":"2021","journal-title":"BioDrugs"},{"key":"10.1016\/j.jpba.2025.117182_bib10","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/rheumatology\/kead525","article-title":"Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases","volume":"63","author":"Jyssum","year":"2024","journal-title":"Rheumatol. (Oxf. )"},{"key":"10.1016\/j.jpba.2025.117182_bib11","doi-asserted-by":"crossref","first-page":"1376708","DOI":"10.3389\/fphar.2024.1376708","article-title":"What are the benefits of therapeutic drug monitoring in the optimization of adalimumab therapy? A systematic review and meta-analysis up to 2022","volume":"15","author":"Li","year":"2024","journal-title":"Front Pharm."},{"key":"10.1016\/j.jpba.2025.117182_bib12","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41575-020-0352-2","article-title":"Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring?","volume":"17","author":"Argollo","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jpba.2025.117182_bib13","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.14309\/ajg.0000000000001396","article-title":"A comprehensive literature review and expert consensus statement on therapeutic drug monitoring of biologics in inflammatory bowel disease","volume":"116","author":"Cheifetz","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jpba.2025.117182_bib14","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/jssc.202200112","article-title":"Approaches for the detection and analysis of antidrug antibodies to biopharmaceuticals: a review","volume":"45","author":"Suh","year":"2022","journal-title":"J. Sep Sci."},{"key":"10.1016\/j.jpba.2025.117182_bib15","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/ecco-jcc\/jjab208","article-title":"Differential Serum-intestinal dynamics of infliximab and adalimumab in inflammatory bowel disease patients","volume":"16","author":"Bar-Yoseph","year":"2022","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.jpba.2025.117182_bib16","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/apt.12030","article-title":"Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays","volume":"36","author":"Vande Casteele","year":"2012","journal-title":"Aliment Pharm. Ther."},{"key":"10.1016\/j.jpba.2025.117182_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.112991","article-title":"Bioanalytical methods for therapeutic monoclonal antibodies and antibody-drug conjugates: a review of recent advances and future perspectives","volume":"179","author":"Todoroki","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117182_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.aca.2019.05.076","article-title":"Six-step workflow for the quantification of therapeutic monoclonal antibodies in biological matrices with liquid chromatography mass spectrometry - a tutorial","volume":"1080","author":"El Amrani","year":"2019","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2025.117182_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116083","article-title":"A validated LC-MS\/MS method for the quantitation of daratumumab in rat serum using rapid tryptic digestion without IgG purification and reduction","volume":"243","author":"Li","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117182_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.115163","article-title":"Development of simple and rapid method for emicizumab quantification by LC-MS\/MS in human plasma","volume":"223","author":"Josset","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117182_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.aca.2019.03.033","article-title":"A multiplex liquid chromatography tandem mass spectrometry method for the quantification of seven therapeutic monoclonal antibodies: application for adalimumab therapeutic drug monitoring in patients with crohn's disease","volume":"1067","author":"Willeman","year":"2019","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2025.117182_bib22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3343\/alm.2023.0468","article-title":"Comparison of Target- and IgG-Enrichment strategies to measure adalimumab concentrations in human plasma using an Immunocapture-Liquid Chromatography-High-Resolution mass spectrometry platform","volume":"44","author":"Ding","year":"2024","journal-title":"Ann. Lab Med"},{"key":"10.1016\/j.jpba.2025.117182_bib23","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.cca.2018.05.015","article-title":"Development and validation of a targeted affinity-enrichment and LC-MS\/MS proteomics approach for the therapeutic monitoring of adalimumab","volume":"483","author":"Yang","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jpba.2025.117182_bib24","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/FTD.0000000000000633","article-title":"Simultaneous quantification of free adalimumab and infliximab in human plasma using a Target-Based sample purification and liquid Chromatography-Tandem mass spectrometry","volume":"41","author":"El Amrani","year":"2019","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2025.117182_bib25","unstructured":"Guidance for industry, bioanalytical method validation, US Department of Health and Human Services, Food and Drug Administration, May 2018."},{"issue":"11","key":"10.1016\/j.jpba.2025.117182_bib26","doi-asserted-by":"crossref","first-page":"831","DOI":"10.4155\/bio-2022-0057","article-title":"Quantification of infliximab and adalimumab in human plasma by a liquid chromatography tandem mass spectrometry kit and comparison with two ELISA methods","volume":"14","author":"Tron","year":"2022","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2025.117182_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.aca.2019.03.033","article-title":"A multiplex liquid chromatography tandem mass spectrometry method for the quantification of seven therapeutic monoclonal antibodies: application for adalimumab therapeutic drug monitoring in patients with crohn's disease","volume":"1067","author":"Willeman","year":"2019","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2025.117182_bib28","doi-asserted-by":"crossref","first-page":"16393","DOI":"10.1038\/s41598-021-95920-9","article-title":"A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis","volume":"11","author":"Rusche","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpba.2025.117182_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.339319","article-title":"Development of an efficient mab quantification assay by LC-MS\/MS using rapid on-bead digestion","volume":"1193","author":"Chiu","year":"2022","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2025.117182_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jchromb.2017.03.044","article-title":"To elute or not to elute in immunocapture bottom-up LC-MS","volume":"1055-1056","author":"Levern\u00e6s","year":"2017","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2025.117182_bib31","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.cgh.2020.03.002","article-title":"Comparison of assays for therapeutic monitoring of infliximab and adalimumab in patients with inflammatory bowel diseases","volume":"19","author":"Papamichael","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.jpba.2025.117182_bib32","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/jalm\/jfad048","article-title":"Comparison of two clinical laboratory assays for measuring serum adalimumab and antibodies to adalimumab","volume":"8","author":"Jain","year":"2023","journal-title":"J. Appl. Lab Med"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525005230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525005230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:42:41Z","timestamp":1773150161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525005230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":32,"alternative-id":["S0731708525005230"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117182","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of active and total adalimumab using affinity purification coupled with tryptic digestion-based liquid chromatography-tandem mass spectrometry analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117182"}}